BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17540426)

  • 1. Activation of p38 mitogen-activated protein kinase by celecoxib oppositely regulates survivin and gamma-H2AX in human colorectal cancer cells.
    Hsiao PW; Chang CC; Liu HF; Tsai CM; Chiu TH; Chao JI
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):97-104. PubMed ID: 17540426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of gamma-H2AX and securin contribute to apoptosis by oxaliplatin via a p38 mitogen-activated protein kinase-dependent pathway in human colorectal cancer cells.
    Chiu SJ; Chao JI; Lee YJ; Hsu TS
    Toxicol Lett; 2008 Jun; 179(2):63-70. PubMed ID: 18499365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxaliplatin down-regulates survivin by p38 MAP kinase and proteasome in human colon cancer cells.
    Liu HF; Hu HC; Chao JI
    Chem Biol Interact; 2010 Dec; 188(3):535-45. PubMed ID: 20708607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baicalein induces cancer cell death and proliferation retardation by the inhibition of CDC2 kinase and survivin associated with opposite role of p38 mitogen-activated protein kinase and AKT.
    Chao JI; Su WC; Liu HF
    Mol Cancer Ther; 2007 Nov; 6(11):3039-48. PubMed ID: 18025287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Celecoxib-induced apoptosis in acute promyelocytic leukemia cell line MR2 and its mechanism].
    Xu Y; Zhao YM; Huang H
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 36(4):319-24. PubMed ID: 17717820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo.
    Pyrko P; Soriano N; Kardosh A; Liu YT; Uddin J; Petasis NA; Hofman FM; Chen CS; Chen TC; Schönthal AH
    Mol Cancer; 2006 May; 5():19. PubMed ID: 16707021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells.
    Chao JI; Kuo PC; Hsu TS
    J Biol Chem; 2004 May; 279(19):20267-76. PubMed ID: 14988404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celecoxib induces p53-PUMA pathway for apoptosis in human colorectal cancer cells.
    Liu HF; Hsiao PW; Chao JI
    Chem Biol Interact; 2008 Oct; 176(1):48-57. PubMed ID: 18760266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
    Chun KS; Kim SH; Song YS; Surh YJ
    Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt.
    Liu B; Shi ZL; Feng J; Tao HM
    Cell Biol Int; 2008 May; 32(5):494-501. PubMed ID: 18078766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential treatment of HPV E6 and E7-expressing TC-1 cells with bortezomib and celecoxib promotes apoptosis through p-p38 MAPK-mediated downregulation of cyclin D1 and CDK2.
    Kim JE; Lee JI; Jin DH; Lee WJ; Park GB; Kim S; Kim YS; Wu TC; Hur DY; Kim D
    Oncol Rep; 2014 May; 31(5):2429-37. PubMed ID: 24627094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatidylinositol 3-kinase inhibition down-regulates survivin and facilitates TRAIL-mediated apoptosis in neuroblastomas.
    Kim S; Kang J; Qiao J; Thomas RP; Evers BM; Chung DH
    J Pediatr Surg; 2004 Apr; 39(4):516-21. PubMed ID: 15065019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of celecoxib on proliferation, apoptosis, and survivin expression in human glioma cell line U251.
    Zhou R; Zhang LZ; Wang RZ
    Chin J Cancer; 2010 Mar; 29(3):294-9. PubMed ID: 20193113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of cyclooxygenase-2 in human HepG2, Bel-7402 and SMMC-7721 hepatoma cell lines and mechanism of cyclooxygenase-2 selective inhibitor celecoxib-induced cell growth inhibition and apoptosis.
    Liu NB; Peng T; Pan C; Yao YY; Shen B; Leng J
    World J Gastroenterol; 2005 Oct; 11(40):6281-7. PubMed ID: 16419156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 protects endothelial cells against gamma-radiation via a Raf-MEK-ERK-survivin signaling pathway that is independent of cytochrome c release.
    Kumar P; Coltas IK; Kumar B; Chepeha DB; Bradford CR; Polverini PJ
    Cancer Res; 2007 Feb; 67(3):1193-202. PubMed ID: 17283155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
    Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
    Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celecoxib inhibits cell proliferation through the activation of ERK and p38 MAPK in head and neck squamous cell carcinoma cell lines.
    Park SW; Kim HS; Hah JW; Jeong WJ; Kim KH; Sung MW
    Anticancer Drugs; 2010 Oct; 21(9):823-30. PubMed ID: 20717005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Survivin gene silencing inhibits the proliferation of human gastric cancer MGC-803 cells and enhances their sensitivity to celecoxib].
    Fang L; Wu HB; Chen XG
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1944-8. PubMed ID: 22126788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective COX-2 inhibitor regulates the MAP kinase signaling pathway in human osteoarthritic chondrocytes after induction of nitric oxide.
    Takahashi T; Ogawa Y; Kitaoka K; Tani T; Uemura Y; Taguchi H; Kobayashi T; Seguchi H; Yamamoto H; Yoshida S
    Int J Mol Med; 2005 Feb; 15(2):213-9. PubMed ID: 15647833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.